UCSF

Sira Medical Wins FDA Clearance for Augmented Reality Preoperative Surgical Planning Software

Retrieved on: 
Wednesday, February 21, 2024
UCSF, SAN, Food, Radiology, Surgeon, Technology management, University, Magnetic resonance imaging, Patient, University of California, Anatomy, Medical imaging

SAN FRANCISCO, Feb. 21, 2024 /PRNewswire/ -- The U.S. Food and Drug Administration granted Sira Medical 510(k) clearance for its augmented reality preoperative surgical planning application, which provides clinicians with advanced imaging to assist in making key patient management decisions.

Key Points: 
  • SAN FRANCISCO, Feb. 21, 2024 /PRNewswire/ -- The U.S. Food and Drug Administration granted Sira Medical 510(k) clearance for its augmented reality preoperative surgical planning application, which provides clinicians with advanced imaging to assist in making key patient management decisions.
  • The lack of clarity forces surgeons to make critical decisions on the fly during surgery, which can lead to errors and inefficiencies.
  • To validate its technology, Sira Medical has conducted multiple peer-reviewed studies which demonstrate greater surgical efficiency by reducing operating time, and a preference for using augmented reality models for surgical planning.
  • "By achieving this major milestone and attracting positive reviews from surgeons, we believe Sira Medical is poised to become a leader in the medical imaging sector."

Kenneth R. Pelletier, PhD, MD Receives 2024 Visionary Award at the Integrative Healthcare Symposium

Retrieved on: 
Saturday, February 17, 2024
CAMPS, UCSF, ASH, MD, NIH, Professor, Public health, Family, Rancho, Clinical professor, Life, University, FACN, Merrell, CNS, Symposium, Stanford University, CHIP

NEW YORK, Feb. 17, 2024 /PRNewswire-PRWeb/ -- Kenneth R. Pelletier, PhD, MD was today named the 2024 Visionary Award recipient at the Integrative Healthcare Symposium, taking place at the Hilton Midtown in New York City.

Key Points: 
  • NEW YORK, Feb. 17, 2024 /PRNewswire-PRWeb/ -- Kenneth R. Pelletier, PhD, MD was today named the 2024 Visionary Award recipient at the Integrative Healthcare Symposium , taking place at the Hilton Midtown in New York City.
  • — Kenneth R. Pelletier, PhD, MD
    Presented each year at the annual Symposium, the Visionary Award recognizes an industry leader whose contributions have shaped integrative healthcare and paved the way for other practitioners and professionals.
  • Dr. Pelletier will also play an active role at the 2024 Integrative Healthcare Symposium, presenting his session "Change Your Genes – Change Your Life: Epigenetics of Longevity" directly following the award ceremony on Saturday, February 17.
  • The 2024 Integrative Healthcare Symposium is held February 15-17, 2024 in New York City.

Global Healthcare Executive Jill DeSimone Joins Swim Across America Board of Directors

Retrieved on: 
Thursday, February 15, 2024
UCSF, Hospital, Teva Pharmaceuticals, Survivor, Merck, Swim Across America, Multimedia, Education, SAA, Dostarlimab, Immunotherapy, FDA, Teva, Friends, Nantucket Cottage Hospital, Growth, Weill Cornell Medicine, Volunteering, Bristol Myers Squibb, Commercial, Sound, Merck & Co., Johns Hopkins University, Health, Patient, Clinical trial, Seattle Cancer Care Alliance, GSK plc, Olympian, Research, Cancer, Pharmaceutical industry

CHARLOTTE, N.C., Feb. 15, 2024 /PRNewswire-PRWeb/ -- Swim Across America, a national nonprofit dedicated to providing grants for cancer research and patient programs and raising funds through swimming events, is pleased to announce that Jill DeSimone, a global pharmaceutical executive, has been appointed to the Swim Across America Board of Directors. Jill's career included championing excellence in patient care for serious diseases, while igniting scalable growth and agility in the healthcare marketplace. She held positions of executive leadership for more than 30 years, culminating in eight years as president of Oncology for Merck.

Key Points: 
  • After a Successful Career with Oncology Pharmaceutical Companies, Jill DeSimone is Making Waves in the Fight Against Cancer
    CHARLOTTE, N.C., Feb. 15, 2024 /PRNewswire-PRWeb/ -- Swim Across America , a national nonprofit dedicated to providing grants for cancer research and patient programs and raising funds through swimming events, is pleased to announce that Jill DeSimone, a global pharmaceutical executive, has been appointed to the Swim Across America Board of Directors.
  • "One of my greatest joys has been volunteering and encouraging many of my colleagues and friends to volunteer with Swim Across America," says Jill DeSimone.
  • "Jill has been supporting Swim Across America for many years," commented Pam Ryan, Swim Across America board chair.
  • Swim Across America was founded in 1987 with its first open water charity swim in Long Island Sound.

Hippocratic AI Launches Nurse Advisory Council to Help Guide Development of Safety-Focused Healthcare LLM

Retrieved on: 
Wednesday, February 14, 2024
Research, Doctor of Philosophy, RN, Case management, Harvard University, Pulse, Lead, LLM, RNC-MNN, Health care, Health, Host, Workforce, Mortality, Health equity, Hippocrates, UCSF, CMSA, BSN, MIT, RNS, Spider-Man, MBA, Broad Institute, Council, Disease, Massachusetts General Hospital, ACM, CCM, Texas Health Resources, Hospital, Digital, Learning, Safety, Knowledge, PALO, Digital health, AI, FAHA, World Health Organization, Entrepreneurship, CMAC, DNP, Patient, Patient safety, Nursing

PALO ALTO, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Hippocratic AI today announced the launch of its Nurse Advisory Council, comprised of registered nurses (RNs) from leading healthcare systems and digital healthcare enterprises.

Key Points: 
  • PALO ALTO, Calif., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Hippocratic AI today announced the launch of its Nurse Advisory Council, comprised of registered nurses (RNs) from leading healthcare systems and digital healthcare enterprises.
  • The Nurse Advisory Council, alongside Hippocratic AI’s Physician Advisory Council , will help shape the company’s safety-focused Large Language Model (LLM) for healthcare and ensure that it is ready for deployment.
  • The Nurse Advisory Council is the latest in a string of collaborative initiatives designed to ensure that Hippocratic AI’s LLM is as safe and impactful as possible.
  • “We designed Hippocratic AI’s Nurse Advisory Council to ensure that their expert insight plays a critical role in our LLM development.

Celebrating Excellence in Anatomy: AAA Awards Distinguished Members

Retrieved on: 
Thursday, February 8, 2024
Pennsylvania State University, Harvard Medical School, California University, Cell biology, The Anatomical Record, Developmental Dynamics, Stanford University, North Carolina State University, Boston Children's Hospital, Public health, School, Cell, Conference, Associate, Medical education, Mentorship, McGill University, Human body, Hospital, Biomedical sciences, Pediatrics, Anatomical Sciences Education, Forensic anthropology, Anschutz Medical Campus, Dental school, Student, University, AAA, Genetics, Outline of health sciences, Research, Physiology, City University, Chemical engineering, Arkansas College, Division, Orthopedic surgery, UCSF, Dentistry

ROCKVILLE, Md., Feb. 8, 2024 /PRNewswire/ -- The American Association for Anatomy (AAA) is honored to announce its 2024 awards recipients. Eighteen of the association's 2,455 members have been selected because they advanced AAA's values: community, respect, inclusion, integrity, and discovery. 

Key Points: 
  • ROCKVILLE, Md., Feb. 8, 2024 /PRNewswire/ -- The American Association for Anatomy (AAA) is honored to announce its 2024 awards recipients.
  • Eighteen of the association's 2,455 members have been selected because they advanced AAA's values: community, respect, inclusion, integrity, and discovery.
  • The AAA awards program provides over $650,000 in awards, research grants, and scholarships annually.
  • "Being recognized by my AAA idols, mentors, and peers is a cherished honor, reaffirming my commitment to fostering curiosity, deep understanding, and innovation in anatomy education."

Ambience Healthcare Raises $70M to Scale the Most Comprehensive AI Operating System for Healthcare Organizations

Retrieved on: 
Tuesday, February 6, 2024
CDI, Memorial Hermann Health System, Elation, EMR, Cerner, SAN, UCSF, Growth, Workflow, Emergency medicine, Language, AI, MD, Clinical trial, Burn, Urology, ROI, Caregiver, Patient, Ecosystem, OpenAI, Entrepreneurship, Documentation, John Muir Health, Brain, CPT, Health care, Doctor of Philosophy, Medicine

SAN FRANCISCO, Feb. 6, 2024 /PRNewswire/ -- Ambience Healthcare , the most comprehensive AI operating system for healthcare organizations, has announced a $70M Series B raise co-led by Kleiner Perkins and OpenAI Startup Fund.

Key Points: 
  • SAN FRANCISCO, Feb. 6, 2024 /PRNewswire/ -- Ambience Healthcare , the most comprehensive AI operating system for healthcare organizations, has announced a $70M Series B raise co-led by Kleiner Perkins and OpenAI Startup Fund.
  • The Ambience AI operating system consists of a holistic suite of applications, designed to alleviate clinician burnout, improve overall system efficiency, and enable high-quality care.
  • Other key technical product features include the ability to:
    By customizing the Ambience AI operating system for each clinical specialty, healthcare systems have seen rapid adoption among clinicians.
  • Ambience's platform approach also enables healthcare organizations to break down silos and achieve significant improvements to overall system efficiency.

FibroGen To Host Part I of Virtual KOL Investor Event Series to Review Pamrevlumab Clinical Program in Pancreatic Cancer on February 13, 2024

Retrieved on: 
Monday, February 5, 2024
SAN, UCSF, University of California, Pancreatic cancer, CTGF, Pamrevlumab, Virginia Mason Medical Center, MMM, ADC, University, KOL, Pancreatic Cancer Action Network, Pharmaceutical industry

SAN FRANCISCO, Feb. 05, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced it will host Part I of a virtual KOL investor event series on Tuesday, February 13, 2024 at 10:30 AM ET.

Key Points: 
  • SAN FRANCISCO, Feb. 05, 2024 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced it will host Part I of a virtual KOL investor event series on Tuesday, February 13, 2024 at 10:30 AM ET.
  • To register, click here .
  • The second event in the series, to be scheduled at a later date, will include a review of the development program for FG-3246; a Phase 2 ready CD46 targeting antibody-drug conjugate (ADC) for the treatment of metastatic castration-resistant prostate cancer (mCRPC).
  • This series is intended for investor audiences only.

Brain Training Improves Social Determinants of Health

Retrieved on: 
Wednesday, January 31, 2024
Anxiety, Memory, Attention, Meal, SAN, UCSF, Hearing, Social, Research, Medicine, NIH, Exercise, Transport, Safety, Incidence, Psychology, University, Ageing, Neuroscience, Arm, Quality of life, Grammatical mood, Dementia, Health, Cognition, E. G. Daily, Fatigue, Conference, Medicare, Dietary supplement

According to Posit Science , the maker of the BrainHQ brain fitness program, that presentation will highlight the role of brain training in addressing non-medical factors that lead to better health.

Key Points: 
  • According to Posit Science , the maker of the BrainHQ brain fitness program, that presentation will highlight the role of brain training in addressing non-medical factors that lead to better health.
  • In recent years, Medicare Advantage (MA) plans have improved their offerings of supplemental benefits to address so-called “Social Determinants of Health” (SDoH) – non-medical factors and conditions (e.g., access to nutrition, transportation, safety, and social engagement) which have been shown to impact health outcomes.
  • MA plans have added a variety of Supplemental Benefits to provide Medicare members with SDoH services (e.g., meals, transportation to appointments, home safety risk reductions, and socialization opportunities).
  • Both are pioneers in the field of brain training, and each has led numerous studies.

WDA Expands Ownership Group with Second Female Leader

Retrieved on: 
Wednesday, January 31, 2024
SPRINT, San Francisco Bay Area, SAN, UCSF, Lead, Marketing, AEC, Commercial Real Estate Women, Community practice, Alaska Airlines, WDA, SJSU, Business development, Super Duper, Commerce, Thought, CREW, Female, Woman, Management

SAN FRANCISCO, Jan. 31, 2024 /PRNewswire/ -- William Duff Architects (WDA) has expanded its ownership to include Sarah Mergy, Director of Business Development and Marketing. Sarah joined the firm five short years ago but has quickly made an impact. She joins Phoebe Lam, Director of Operations, as the second female owner.

Key Points: 
  • SAN FRANCISCO, Jan. 31, 2024 /PRNewswire/ -- William Duff Architects (WDA) has expanded its ownership to include Sarah Mergy , Director of Business Development and Marketing.
  • She joins Phoebe Lam , Director of Operations, as the second female owner.
  • Sarah's professional career in the A/E/C industry spans over 20 years' experience in operations, marketing, design and business development.
  • At WDA, she is also a member of the firm's Management team working to drive growth-oriented marketing and business strategy.

Harmonic Discovery Announces Licensing Agreement with BioVentures and UCSF for FLT3 Mutated AML Development Program

Retrieved on: 
Tuesday, January 30, 2024
Medicine, UCSF, Acute myeloid leukemia, MD, Pharmacology, University of Arkansas, IND, Patient, AML, FLT3, Laboratory, Patent, Doctor of Philosophy, University, Aplastic anemia, Pharmaceutical industry

The compound, named HD-10019, is currently in pre-clinical development and is expected to commence IND-enabling studies in late 2024.

Key Points: 
  • The compound, named HD-10019, is currently in pre-clinical development and is expected to commence IND-enabling studies in late 2024.
  • HD-10019 is a type II kinase inhibitor that was rationally designed to overcome tyrosine kinase domain resistance mutations in the FLT3 kinase and improve myelosuppression versus standard of care agents for FLT3 mutated AML.
  • "We are excited to work with BioVentures and UCSF and take a step forward in delivering a novel treatment to FLT3 mutated AML patients," said Rayees Rahman, PhD, CEO of Harmonic Discovery.
  • Wilson Sonsini Goodrich & Rosati served as legal advisor to Harmonic Discovery on matters relating to the Licensing Agreement and related corporate and patent strategy matters.